- Border adjustment tax or BAT is a tax levied on imports into the US
- The charge is expected to create a level playing field for local manufacturers in the US
- Most Indian companies export their products to the US
- Levying BAT could make Indian medicines expensive in the US
- To remain competitive, Indian companies may have to take a hit on their operating margins
- Trump plans to increase local hiring in IT jobs and reduce work permit visas from India
- Mandatory increase in minimum wages will also add to cost pressures
What’s hot, what's not
Preferred Stocks | Stocks to avoid |
ONGC | Infosys |
Petronet LNG | TCS |
Gail | Tech Mahindra |
L&T | Mindtree |
Grasim | Glenmark Pharma |
Vedanta | Lupin |
State Bank of India | Aurobindo Pharma |
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in